Exploring the neuromagnetic signatures of cognitive decline from mild cognitive impairment to Alzheimer’s disease dementia
View ORCID ProfileSinead Gaubert, View ORCID ProfilePilar Garces, View ORCID ProfileJörg Hipp, View ORCID ProfileRicardo Bruña, View ORCID ProfileMaria Eugenia Lopéz, View ORCID ProfileFernando Maestu, View ORCID ProfileDelshad Vaghari, View ORCID ProfileRichard Henson, View ORCID ProfileClaire Paquet, View ORCID ProfileDenis Engemann
doi: https://doi.org/10.1101/2024.07.06.24310016
Sinead Gaubert
1Université Paris Cité, Inserm UMRS 1144 Therapeutic Optimization in Neuropsychopharmacology, Paris, France
2Cognitive Neurology Center, GHU.Nord APHP Hôpital Lariboisière Fernand Widal, Paris, France
Pilar Garces
3Roche Pharma Research and Early Development, Neuroscience and Rare Diseases, Roche Innovation Center Basel, F. Hoffmann–La Roche Ltd., Basel, Switzerland
Jörg Hipp
3Roche Pharma Research and Early Development, Neuroscience and Rare Diseases, Roche Innovation Center Basel, F. Hoffmann–La Roche Ltd., Basel, Switzerland
Ricardo Bruña
4Center for Cognitive and Computational Neuroscience, Complutense University of Madrid, 28223, Madrid, Spain
5Department of Experimental Psychology, Cognitive Processes and Speech Therapy, Complutense University of Madrid, Madrid, Spain
Maria Eugenia Lopéz
5Department of Experimental Psychology, Cognitive Processes and Speech Therapy, Complutense University of Madrid, Madrid, Spain
Fernando Maestu
5Department of Experimental Psychology, Cognitive Processes and Speech Therapy, Complutense University of Madrid, Madrid, Spain
Delshad Vaghari
6Department of Psychology, University of Cambridge, UK
Richard Henson
7MRC Cognition and Brain Sciences Unit, University of Cambridge, CB2 7EF, UK
8Department of Psychiatry, University of Cambridge, UK
Claire Paquet
1Université Paris Cité, Inserm UMRS 1144 Therapeutic Optimization in Neuropsychopharmacology, Paris, France
2Cognitive Neurology Center, GHU.Nord APHP Hôpital Lariboisière Fernand Widal, Paris, France
Denis Engemann
3Roche Pharma Research and Early Development, Neuroscience and Rare Diseases, Roche Innovation Center Basel, F. Hoffmann–La Roche Ltd., Basel, Switzerland
Data Availability
BioFIND is a controlled access repository and access is institutionally granted.
Posted July 07, 2024.
Exploring the neuromagnetic signatures of cognitive decline from mild cognitive impairment to Alzheimer’s disease dementia
Sinead Gaubert, Pilar Garces, Jörg Hipp, Ricardo Bruña, Maria Eugenia Lopéz, Fernando Maestu, Delshad Vaghari, Richard Henson, Claire Paquet, Denis Engemann
medRxiv 2024.07.06.24310016; doi: https://doi.org/10.1101/2024.07.06.24310016
Exploring the neuromagnetic signatures of cognitive decline from mild cognitive impairment to Alzheimer’s disease dementia
Sinead Gaubert, Pilar Garces, Jörg Hipp, Ricardo Bruña, Maria Eugenia Lopéz, Fernando Maestu, Delshad Vaghari, Richard Henson, Claire Paquet, Denis Engemann
medRxiv 2024.07.06.24310016; doi: https://doi.org/10.1101/2024.07.06.24310016
Subject Area
Subject Areas
- Addiction Medicine (383)
- Allergy and Immunology (699)
- Anesthesia (192)
- Cardiovascular Medicine (2841)
- Dermatology (243)
- Emergency Medicine (428)
- Epidemiology (12551)
- Forensic Medicine (10)
- Gastroenterology (803)
- Genetic and Genomic Medicine (4425)
- Geriatric Medicine (401)
- Health Economics (715)
- Health Informatics (2849)
- Health Policy (1047)
- Hematology (375)
- HIV/AIDS (893)
- Medical Education (413)
- Medical Ethics (114)
- Nephrology (461)
- Neurology (4184)
- Nursing (222)
- Nutrition (617)
- Oncology (2200)
- Ophthalmology (623)
- Orthopedics (254)
- Otolaryngology (318)
- Pain Medicine (267)
- Palliative Medicine (81)
- Pathology (486)
- Pediatrics (1171)
- Primary Care Research (482)
- Public and Global Health (6775)
- Radiology and Imaging (1487)
- Respiratory Medicine (899)
- Rheumatology (430)
- Sports Medicine (369)
- Surgery (473)
- Toxicology (57)
- Transplantation (200)
- Urology (174)